−/− mouse embryonic fibroblasts is essentially intact and retains basal transcription functions and coactivator functions for other activators (Malik et al., 2004) , suggesting a tangential association of MED1/TRAP220 with the complex. Therefore, these data raise an important question as to whether MED1/TRAP220 is an integral core subunit of all TRAP/Mediator complexes or whether it exists only in a specialized TRAP/Mediator complex that subserves specific functions.
Toward a better understanding of the role of MED1/ TRAP220 and cognate TRAP/Mediator complexes in nuclear receptor function, this study has investigated, through structural and functional studies, heterogeneity within TRAP/Mediator complexes, with a special focus on the MED1/TRAP220-containing TRAP/Mediator. Beyond demonstrating a MED1/TRAP220-and RNA poly- growth in a breast cancer cell line that is readily amendable to such analyses. Apart from demonstrating a critical role for MED1/TRAP220 in ER-dependent functions, our studies provide evidence for the differential utilizaIsolation and Characterization of MED1/TRAP220-tion of the newly defined MED1/TRAP220-containing Containing TRAP/Mediator from Nuclear Extracts and MED1/TRAP220-deficient TRAP/Mediator complexes To better understand structural and functional similariin distinct gene activation events. ties and differences between the MED1/TRAP220-containing TRAP/Mediator subpopulation and the total TRAP/Mediator population and to avoid possible disResults ruption of complexes by prior chromatographic steps, we purified MED1/TRAP220-containing TRAP/Mediator MED1/TRAP220 Exists Only in a Subpopulation directly from nuclear extracts by using anti-MED1/ of TRAP/Mediator Complexes TRAP220 antibodies. Total TRAP/Mediator complex Nuclear extracts were repeatedly passed through an was purified directly from unfractionated nuclear exanti-MED1/TRAP220 antibody column, and the flowtracts derived from a cell line expressing FLAG-tagged through fractions were collected and subjected to sodium MED10/NUT2 (Malik and Roeder, 2000) , a core subunit dodecyl sulfate-polyacrylamide gel electrophoresis of the TRAP/Mediator complex, by using M2-agarose (SDS-PAGE) and immunoblot analyses. A mock-depleted under the same conditions. Immunoblot analyses indiextract treated with preimmune antibodies served as a cated that anti-MED1/TRAP220 antibody and anticontrol. The anti-MED1/TRAP220 antibodies quantita-FLAG (M2-agarose) antibody immunoprecipitated all tively removed MED1/TRAP220, whereas the levels of TRAP/Mediator subunits tested, whereas preimmune TATA-Binding Protein (TBP) and TFIIH (p65), compoantibody did not (Figure 2A) . A comparison of the subnents of the general transcription machinery, were ununit levels relative to the amounts of MED17/TRAP80 affected (Figure 1) . Surprisingly, however, a significant in these two preparations clearly revealed that MED1/ level (at least 80%) of all other TRAP/Mediator subunits TRAP220 is enriched (about 5-fold) in the anti-MED1/ tested still remained in the MED1/TRAP220-depleted TRAP220 preparation, whereas most other tested subnuclear extract. This result contrasts with our earlier units showed very similar levels in both preparations. observation of essentially complete depletion of all Gel-filtration of nuclear extracts on S300 Sephedex re-TRAP/Mediator subunits by antibodies against the invealed a single MED1/TRAP220 peak (at about form. Therefore, we conclude that MED1/TRAP220 is rations were subjected to Mass Spectrometry (MS) analyses as described in the Experimental Procedures. markedly underrepresented (substoichiometeric) in the total TRAP/Mediator population.
MS data indicated that both TRAP/Mediator preparations are highly pure, and all TRAP/Mediator subunits We next examined the two TRAP/Mediator preparations by silver stain to assess potential differences in detected in these two preparations are listed in Table  S1 (see Table S1 in the Supplemental Data available their compositions. Consistent with the immunoblot results, the anti-MED1/TRAP220 and FLAG-MED10/NUT2 with this article online). The FLAG-MED10/NUT2 preparation contains, in adpreparations showed the expected subunit patterns ( Figures 2B and 2C) TRAP220, the requirement of MED1/TRAP220 for ERThese analyses utilized an estrogen-dependent breast mediated transcription was examined by using RNA incancer cell line, MCF-7, that shows a strong and relaterference to reduce intracellular MED1/TRAP220 levels. tively rapid induction of several well-characterized MED1/TRAP220 siRNAs selectively reduced MED1/ genes in response to estrogen. Chromatin IP experi-TRAP220 protein to about 10% of the wild-type level ments revealed little or no p53, MED21/SRB7, or MED1/ ( Figure 6A ) and significantly impaired estrogen-depen-TRAP220 on the estrogen-responsive pS2 promoter bedent activation of the ERE-TK-Luc reporter gene but, fore estrogen treatment, whereas high levels of MED21/ importantly, showed minimal effects on expression of the control TK-Luc reporter gene ( Figure 6B ). An addi-SRB7 and MED1/TRAP220, but not p53, were recruited tional control with GFP siRNA showed no effect on to the pS2 promoter after estrogen treatment (Figure ERE-TK-LUC activity, indicating the specificity of the 5A, top). These observations are consistent with previ-MED1/TRAP220 siRNA ( Figure 6C ). ous reports of MED1/TRAP220/PBP and ER recruitTo examine MED1/TRAP220 siRNA effects on endogment to the pS2 gene in response to estrogen (Shang enous ER target gene expression, reverse transcripet al., 2000). As controls, occupancy of the p53-respontase-polymerase chain reaction (RT-PCR) was carried sive p21 promoter by these factors was examined. A out on the cathepsin-D gene (to which MED1/TRAP220 low but significant (basal) level of all three proteins was is also recruited in response to estrogen stimulation, observed on the p21 promoter prior to estrogen treatbut not UV irradiation; Figure S2 ). Consistent with the ment, consistent with the basal level of p21 expression above observations, estrogen-dependent activation of in U2OS cells (Espinosa et al., 2003) . Importantly, howcathepsin-D mRNA expression also was blocked by ever, their levels did not change after estrogen induc-MED1/TRAP220 siRNA ( Figure 6D ). Because MED1/ tion ( Figure 5A, bottom) , indicating the promoter speci-TRAP220 does not interact with p53 and is neither reficity of ER function and MED1/TRAP220 recruitment. quired for p53-mediated transcriptional activation nor In contrast to the results with estrogen treatment, UV recruited to a p53 target gene promoter in response to irradiation resulted in a significant and selective inp53 activation by UV treatment, another control expericrease of p53 recruitment to the p21 promoter (Figure ment was designed to examine the effect of MED1/ 5B, bottom). UV irradiation also resulted in an increased TRAP220 siRNA on p53 target-gene expression. Imporoccupancy of MED21/SRB7 on the p21 promoter, inditantly, and as expected, MED1/TRAP220 siRNA did not cating UV-dependent recruitment of TRAP/Mediator to affect activation of the MDM2-Luc reporter by p53 (Figthis promoter . Interestingly, however, in contrast to the ure 6E). These data further confirm the specificity of increased recruitment of p53 and MED21/SRB7, no sig-MED1/TRAP220 siRNA treatment. In summary, all these nificant increase in MED1/TRAP220 recruitment to the data indicate that MED1/TRAP220 is selectively rep21 promoter was observed after UV treatment. As quired for ER-mediated target-gene expression. controls, no p53, MED21/SRB7, or MED1/TRAP220 was detected on the pS2 promoter in response to UV treatment ( Figure 5B, top) . These data clearly indicate
MED1/TRAP220 Plays an Essential Role in Mediating Estrogen-Dependent Growth of MCF-7 Cells a selective recruitment of two different TRAP/Mediator populations by p53 and ER upon target gene activation
It is well known that estrogen-mediated functions in regulating mammary gland development and in proby UV and estrogen, respectively. Comparable results 
